| CAS: | 123408-74-2 | |
| 分子式: | C32H63NO3 | |
| 分子量: | 509.85 | |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||
| N984020 | MACKLIN | N-肉豆蔻酰-D-赤型-神经鞘氨醇 | 700元/5mg; | 咨询 | |||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||
| 860514P | Avanti | C14 Ceramide (d18:1/14:0) | Avanti Polar Lipids 860514P, powder | 910.62元/5 MG; | 咨询 | ||||||||||||||||||||||
产品说明 一般描述 Ceramide synthesis is majorly driven by de novo pathway involving the palmitoyl-CoA and 应用 C14 Ceramide (d18:1/14:0) is suitable for use
生化/生理作用 Ceramides regulate biological processes including proliferation, differentiation and apoptosis. In the cystic fibrosis patients, elevated levels of C14 ceramide is observed. It is also a potential biomarker for hepatic steatosis (HS) and C14 ceramide levels correlate with the aspartate aminotransferase (AST) / alanine transaminase (ALT) ratio. Tumor necrosis factor α (TNFα) mediates increase in the C14 levels. Fumonisin B1 prevents the C14 accumulation. 包装 5 mL Amber Glass Screw Cap Vial (860514P-25mg) 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||